Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is ...

NS Partners Ltd reduced its stake in Johnson & Johnson by 3.7%, selling 3,012 shares in Q4. The institutional investor now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), ...

Johnson & Johnson claims a federal judge wrongfully granted its investors class certification for losses related to purported ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BridgeBio Pharma (BBIO – Research Report), ...

Guggenheim reiterated their neutral rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. JNJ has been the topic of ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a ...